In short
Off-label drug use is sometimes a reasonable clinical need but carries safety and legal risk. China's 2021 management guideline (Peking Union + Lanzhou University) sets the first standardized, governed procedure for it.
What this guide covers: What is off-label use? · The first national management guideline · Core principles · What it means for patients
What is off-label use?
Off-label use means prescribing a drug for an indication, dose, or population not in its approved label. Sometimes it is a reasonable clinical need, but it carries medication-safety and legal risks. China had no management guideline until this 2021 document.
The first national management guideline
Led by Peking Union Medical College Hospital with Lanzhou University's Evidence-based Medicine Center, the 2021 guideline addresses 9 key questions with graded recommendations, aligned with the PRC Physicians Law and WHO guideline methods.
Core principles
Hospitals should have a standardized off-label management procedure: justify the use with evidence, obtain informed consent, document the decision, and provide oversight. It is not a blanket permission but a governed process.
What it means for patients
If a drug is used off-label in your care, you should be informed and asked for consent, with the rationale documented. You may ask your physician or hospital about the evidence and safeguards behind any off-label choice.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.


